UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weight gain on antipsychotics – A perfect storm of complex pathophysiology and psychopharmacology

Acta psychiatrica Scandinavica, 2021-12, Vol.144 (6), p.521-523

2021

Volltextzugriff (PDF)

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

Cochrane database of systematic reviews, 2018-03, Vol.3 (3), p.CD011481

2018

Volltextzugriff (PDF)

Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment

JAMA psychiatry (Chicago, Ill.), 2016-02, Vol.73 (2), p.121

2016

Volltextzugriff (PDF)

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

Expert opinion on drug safety, 2019-12, Vol.18 (12), p.1149-1160

2019

Volltextzugriff (PDF)

Risk factors for long‐term cognitive impairment in ICU survivors: A multicenter, prospective cohort study

Acta anaesthesiologica Scandinavica, 2021-01, Vol.65 (1), p.92-99

2021

Volltextzugriff (PDF)

Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review

Expert opinion on pharmacotherapy, 2023-11, Vol.24 (16), p.1823-1832

2023

Volltextzugriff (PDF)

Associations between cortical thickness and auditory verbal hallucinations in patients with schizophrenia: A systematic review

Psychiatry research. Neuroimaging, 2018-12, Vol.282, p.31-39

2018

Volltextzugriff (PDF)

Pragmatic antipsychotics trial—caution in interpretation

The Lancet. Psychiatry, 2021-02, Vol.8 (2), p.100-101

2021

Volltextzugriff (PDF)

Increased use of coercive procedures and prolonged hospitalization in compulsory admitted psychotic patients, who refuse antipsychotic medication

Nordic journal of psychiatry, 2020-07, Vol.74 (5), p.1-326

2020

Volltextzugriff (PDF)

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients

Frontiers in neuroscience, 2020-05, Vol.14, p.484-484

2020

Volltextzugriff (PDF)

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

The international journal of neuropsychopharmacology, 2014-11, Vol.17 (11), p.1729-1736

2014

Volltextzugriff (PDF)

Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia

Schizophrenia (Heidelberg, Germany), 2024-08, Vol.10 (1), p.1-9, Article 72

2024

Volltextzugriff (PDF)

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

The American journal of psychiatry, 2017-03, Vol.174 (3), p.216-229

2017

Volltextzugriff (PDF)

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

Cochrane library, 2015-01

2015

Volltextzugriff (PDF)

Haloperidol for the Treatment of Delirium in ICU Patients

The New England journal of medicine, 2022-12, Vol.387 (26), p.2425-2435

2022

Volltextzugriff (PDF)

Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis

Diabetes, obesity & metabolism, 2019-02, Vol.21 (2), p.293-302

2019

Volltextzugriff (PDF)

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

Psychological medicine, 2020-10, Vol.50 (13), p.2182-2193

2020

Volltextzugriff (PDF)

Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis

JAMA psychiatry (Chicago, Ill.), 2021-07, Vol.78 (7), p.753

2021

Volltextzugriff (PDF)

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients

Psychological medicine, 2019-12, Vol.49 (16), p.2754-2763

2019

Volltextzugriff (PDF)

Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade

Journal of psychiatry & neuroscience, 2016-03, Vol.41 (2), p.133-141

2016

Volltextzugriff (PDF)

Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

Psychological medicine, 2019-04, Vol.49 (5), p.868-875

2019

Volltextzugriff (PDF)

Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D2 Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response

Biological psychiatry (1969), 2022-01, Vol.91 (2), p.236-245

2022

Volltextzugriff (PDF)

Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trial

BMC psychiatry, 2023-08, Vol.23 (1), p.1-13, Article 634

2023

Volltextzugriff (PDF)

Treatment of schizotypal disorder: a protocol for a systematic review of the evidence and recommendations for clinical practice

BMJ open, 2023-11, Vol.13 (11), p.e075140-e075140

2023

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(143)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(103)
Science & Technology
(103)
Psychiatry
(82)
Humans
(66)
Schizophrenia
(52)
Adult
(36)
Female
(33)
Male
(33)
Schizophrenia - Drug Therapy
(30)
Antipsychotics
(28)
Neurosciences & Neurology
(28)
Neurosciences
(27)
Young Adult
(25)
Mental Disorders
(23)
Psychotropic Drugs
(23)
Antipsychotic Agents - Therapeutic Use
(22)
Psychosis
(21)
Magnetic Resonance Imaging
(19)
Cognition
(18)
Antipsychotic Agents - Adverse Effects
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Weight gain on antipsychotics – A perfect storm of complex pathophysiology and psychopharmacology

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

Risk factors for long‐term cognitive impairment in ICU survivors: A multicenter, prospective cohort study

Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review

Associations between cortical thickness and auditory verbal hallucinations in patients with schizophrenia: A systematic review

Pragmatic antipsychotics trial—caution in interpretation

Increased use of coercive procedures and prolonged hospitalization in compulsory admitted psychotic patients, who refuse antipsychotic medication

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

Haloperidol for the Treatment of Delirium in ICU Patients

Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients

Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade

Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D2 Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years

Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trial

Treatment of schizotypal disorder: a protocol for a systematic review of the evidence and recommendations for clinical practice

Suchergebnisse filtern